Absence of association between genetic variation in the promoter of the microsomal triglyceride transfer protein gene and plasma lipoproteins in the Framingham Offspring Study

Atherosclerosis

Volumn 148, Issue 2, 2000, Pages 337-343

  Couture, Patrick ^a   Otvos, James D ^b   Cupples, L Adrienne ^c   Wilson, Peter W F ^d   Schaefer, Ernst J ^a   Ordovas, Jose M ^a  

^a TUFTS UNIVERSITY   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^d FRAMINGHAM HEART STUDY   (United States)

Author keywords

LDL cholesterol; Lipoprotein subfractions; Microsomal triglyceride transfer protein

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CARRIER PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; AUTOMATION; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENDER; GENE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MALE; MICROSOME; MUTATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ONSET AGE; POPULATION RESEARCH; PRIORITY JOURNAL; PROMOTER REGION;

ADULT; APOLIPOPROTEINS; CARDIOVASCULAR DISEASES; CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLYCOPROTEINS; HUMANS; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); PROSPECTIVE STUDIES; VARIATION (GENETICS);

EID: 0033984745     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00281-6     Document Type: Article

References (37)

1. Castelli W.P., Anderson K., Wilson P.W., Levy D. Lipids and risk of coronary heart disease. The Framingham Study. Ann. Epidemiol. 2:1992;23-28.
2. Lamarche B., Tchernof A., Moorjani S., Cantin B., Dagenais G.R., Lupien P.J., Despres J.P. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Circulation. 95:1997;69-75.
3. Austin M.A., Breslow J.L., Hennekens C.H., Buring J.E., Willett W.C., Krauss R.M. Low-density lipoprotein subclass patterns and risk of myocardial infarction. J. Am. Med. Assoc. 260:1988;1917-1921.
4. Griffin B.A., Freeman D.J., Tait G.W., Thomson J., Caslake M.J., Packard C.J., Shepherd J., Schaefer E.J. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Arteriosclerosis. 106:1994;241-253.
5. Campos H., Genest J.J. Jr, Blijlevens E., McNamara J.R., Jenner J.L., Ordovas J.M., Wilson P.W., Schaefer E.J. Low density lipoprotein particle size and coronary artery disease. Arterioscler. Thromb. 12:1992;187-195.
6. Gardner C.D., Fortmann S.P., Krauss R.M. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. J. Am. Med. Assoc. 276:1996;875-881.
7. Brown M.S., Goldstein J.L. A receptor-mediated pathway for cholesterol homeostasis. Science. 232:1986;34-47.
8. Wu X., Zhou M., Huang L.S., Wetterau J., Ginsberg H.N. Demonstration of a physical interaction between microsomal triglyceride transfer protein and apolipoprotein B during the assembly of ApoB-containing lipoproteins. J. Biol. Chem. 271:1996;10277-10281.
9. Gordon D.A., Jamil H., Sharp D., Mullaney D., Yao Z., Gregg R.E., Wetterau J. Secretion of apolipoprotein B-containing lipoproteins from HeLa cells is dependent on expression of the microsomal triglyceride transfer protein and is regulated by lipid availability. Proc. Natl. Acad. Sci. USA. 91:1994;7628-7632.
10. Wetterau J.R., Zilversmit D.B. Localization of intracellular triacylplycerol and cholesteryl ester transfer activity in rat tissues. Biochim. Biophys. Acta. 875:1986;610-617.
11. Boren J., Veniant M.M., Young S.G. Apo B100-containing lipoproteins are secreted by the heart. J. Clin. Invest. 101:1998;1197-1202.
12. Jamil H., Gordon D.A., Eustice D.C., Brooks C.M., Dickson J.K. Jr, Chen Y., Ricci B., Chu C.H., Harrity T.W., Ciosek C.P. Jr, Biller S.A., Gregg R.E., Wetterau J.R. An inhibitor of the microsomal triglyceride transfer protein inhibits apoB secretion from HepG2 cells. Proc. Natl. Acad. Sci USA. 93:1996;11991-11995.
13. Haghpassand M., Wilder D., Moberly J.B. Inhibition of apolipoprotein B and triglyceride secretion in human hepatoma cells (HepG2). J. Lipid. Res. 37:1996;1468-1480.
14. Wetterau J.R., Aggerbeck L.P., Bouma M.E., Eisenberg C., Munck A., Hermier M., Schmitz J., Gay G., Rader D.J., Gregg R.E. Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science. 258:1992;999-1001.
15. Rehberg E.F., Samson-Bouma M.E., Kienzle B., Blinderman L., Jamil H., Wetterau J.R., Aggerbeck L.P., Gordon D.A. A novel abetalipoproteinemia genotype. Identification of a missense mutation in the 97-kDa subunit of the microsomal triglyceride transfer protein that prevents complex formation with protein distilfide isomerase. J. Biol. Chem. 271:1996;29945-29952.
16. Kane J.P., Havel R.J. Disorders of the biogenesis and secretion of lipoproteins containing the B apolipoproteins. Scriver C.R., Beaudet A.L., Sly W.S., Valle D. The Metabolic Basis of Inherited Diseases. 1995;1853-1885 McGraw-Hill, NewYork.
17. Hagan D.L., Kienzle B., Jamil H., Hariharan N. Transcriptional regulation of human and hamster microsomal triglyceride transfer protein genes. Cell type-specific expression and response to metabolic regulators. J. Biol. Chem. 269:1994;28737-28744.
18. Lin M.C., Gordon D., Wetterau J.R. Microsomal triglyceride transfer protein (MTP) regulation in HepG2 cells: insulin negatively regulates MTP gene expression. J. Lipid Res. 36:1995;1073-1081.
19. Karpe F., Lundahl B., Ehrenborg E., Eriksson P., Hamsten A. A common functional polymorphism in the promoter region of the microsomal triglyceride transfer protein gene influences plasma LDL levels. Arterioscler. Thromb. Vasc. Biol. 18:1998;756-761.
20. Feinleib M., Kannel W.B., Garrison R.J., McNamara P.M., Castelli W.P. The Framingham Offspring Study. Design and preliminary data. Prev. Med. 4:1975;518-525.
21. Kannel W.B., Feinleib M., McNamara P.M., Garrison R.J., Castelli W.P. An investigation of coronary heart disease in families. The Framingham offspring study. Am. J. Epidemiol. 110:1979;281-290.
22. Dawber T.R., Meadors G.F., Moore R. Epidemiological approach to heart disease: The Framingham Study. Am. J. Public Health. 41:1951;279-286.
23. Cupples L.A., Gagnon D.R., Kannel W.B. Long- and short-term risk of sudden coronary death. Circulation. 85:1992;111-118.
24. 2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin. Chem. 28:1982;1379-1388.
25. Lipid Research Clinic Program. The Coronary Primary Prevention Trial: design and implementation, J Chronic Dis 1979;14:1250-1257.
26. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18:1972;499-502.
27. McNamara J., Schaefer E. Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. Clin. Chim. Acta. 166:1987;1-8.
28. Schaefer E., Ordovas J. Metabolism of apolipoproteins A-I, A-II, and A-IV. Methods Enzymol. 129:1986;420-443.
29. Ordovas J.M., Peterson J.P., Santaniello P., Cohn J.S., Wilson P.W., Schaefer E.J. Enzyme-linked immunosorbent assay for human plasma apolipoprotein B. J. Lipid Res. 28:1987;1216-1224.
30. Otvos J.D., Jeyarajah E.J., Bennett D.W., Krauss R.M. Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement. Clin. Chem. 38:1992;1632-1638.
31. Otvos J.D. Measurement of lipoprotein subclass profile by nuclear magnetic resonance. Rifai N., Warnick G.R., Dominiczak M.H. Handbook of Lipoprotein Testing. 1997;497-508 MCC press, Washington, DC.
32. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1988;12-15.
33. Boerwinkle E., Utermann G. Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism. Am. J. Hum. Genet. 42:1988;104-112.
34. Almasy L., Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am. J. Hum. Genet. 62:1998;1198-1211.
35. Sharp D., Blinderman L., Combs K.A., Kienzle B., Ricci B., Wager-Smith K., Gil C.M., Turck C.W., Bouma M.E., Rader D.J. et al. Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinaemia. Nature. 365:1993;65-69.
36. Shoulders C.C., Brett D.J., Bayliss J.D., Narcisi T.M., Jarmuz A., Grantham T.T., Leoni P.R., Bhattacharya S., Pease R.J., Cullen P.M. et al. Abetalipoproteinemia is caused by defects of the gene encoding the 97 kDa subunit of a microsomal triglyceride transfer protein. Hum. Mol. Genet. 2:1993;2109-2116.
37. Herrmann S.M., Poirier O., Nicaud V., Evans A., Ruidavets J.B., Luc G., Arveiler D., Bao-Sheng C., Cambien F. Identification of two polymorphisms in the promoter of the microsomal triglyceride transfer protein (MTP) gene. Lack of association with lipoprotein profiles. J. Lipid Res. 39:1998;2432-2435.